{"id":350590,"date":"2025-08-25T19:47:18","date_gmt":"2025-08-25T19:47:18","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-ascendis-pharma-as\/"},"modified":"2025-08-25T19:47:18","modified_gmt":"2025-08-25T19:47:18","slug":"how-to-buy-ascendis-pharma-as","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/","title":{"rendered":"How to buy Ascendis Pharma A\/S (ASND) shares &#8211; Investment in Ascendis Pharma A\/S (ASND) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-350590","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Ascendis Pharma A\/S (ASND) Shares - Investment in Ascendis Pharma A\/S (ASND) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Ascendis Pharma A\/S (ASND) Shares - Investment in Ascendis Pharma A\/S (ASND) Stock"},"description":"Learn how to invest in Ascendis Pharma A\/S (ASND) stock with current price analysis, risk assessment, and step-by-step buying process for 2025-2030 growth potential.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to invest in Ascendis Pharma A\/S (ASND) stock with current price analysis, risk assessment, and step-by-step buying process for 2025-2030 growth potential."},"intro":"Thinking about tapping into the booming biotech sector? Ascendis Pharma A\/S (ASND) represents one of the most exciting growth stories in rare disease treatments. With their revolutionary TransCon technology platform and explosive revenue growth, this Danish innovator could be your ticket to substantial returns. Let's break down everything you need to know about investing in this pharmaceutical powerhouse.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about tapping into the booming biotech sector? Ascendis Pharma A\/S (ASND) represents one of the most exciting growth stories in rare disease treatments. With their revolutionary TransCon technology platform and explosive revenue growth, this Danish innovator could be your ticket to substantial returns. Let's break down everything you need to know about investing in this pharmaceutical powerhouse."},"body_html":"<h2>\ud83d\udcc8 Ascendis Pharma Stock: Current Price and Critical Dates<\/h2> <p>As of August 25, 2025, Ascendis Pharma A\/S (ASND) trades at <strong>$194.30<\/strong> on NASDAQ. Mark your calendar: <strong>November 13, 2025<\/strong> is absolutely critical\u2014that's when the company releases its Q3 earnings report. But the real game-changer comes just before that...<\/p> <p><strong>November 30, 2025<\/strong> is the FDA's PDUFA date for TransCon CNP approval. This single decision could make or break the stock's trajectory for the next year. Historically, FDA decisions on Ascendis products have created massive price swings.<\/p> <h3>How FDA Decisions Move ASND Stock<\/h3> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 2024<\/td><td>YORVIPATH Approval<\/td><td>$145<\/td><td>+28% (1 week)<\/td><\/tr> <tr><td>Mar 2025<\/td><td>SKYTROFA Expansion<\/td><td>$168<\/td><td>+15% (3 days)<\/td><\/tr> <tr><td>Jan 2025<\/td><td>Clinical Trial Results<\/td><td>$132<\/td><td>-12% (disappointing data)<\/td><\/tr> <\/tbody> <\/table> <p>The pattern is clear: positive regulatory news drives double-digit gains, while setbacks cause significant corrections. The November decision represents the biggest catalyst of 2025.<\/p> <h3>6-Month Price Journey (February-August 2025)<\/h3> <p>ASND shares delivered an impressive <strong>75% surge<\/strong> during this period:<\/p> <ul> <li><strong>February<\/strong>: $111.09 (52-week low, market uncertainty)<\/li> <li><strong>April<\/strong>: $150.12 (breaking through 200-day moving average)<\/li> <li><strong>June<\/strong>: $188.79 (approaching all-time highs)<\/li> <li><strong>August<\/strong>: $194.30 (consolidating near peak levels)<\/li> <\/ul> <p>Why the dramatic climb? Three words: <strong>explosive revenue growth<\/strong>. The company's Q2 2025 results showed a staggering <strong>339% revenue increase<\/strong> to \u20ac158 million, driven by successful launches of YORVIPATH and SKYTROFA.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <ul> <li><strong>2025 Year-End<\/strong>: $220-240 (pending FDA approval) \u2192 <strong>STRONG BUY<\/strong> if approved<\/li> <li><strong>2026<\/strong>: $260-300 (full commercialization of TransCon CNP)<\/li> <li><strong>2028<\/strong>: $380-450 (pipeline expansion and international growth)<\/li> <li><strong>2030<\/strong>: $550-650 (market leadership in endocrine rare diseases)<\/li> <\/ul> <p>The verdict? This is a <strong>high-risk, high-reward opportunity<\/strong> perfect for investors who can stomach biotech volatility. The November FDA decision is everything\u2014approval could launch this stock into orbit.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>FDA rejection risk<\/strong>: 20-30% potential drop if TransCon CNP isn't approved<\/li> <li><strong>Financial losses<\/strong>: \u20ac38.9M net loss despite huge revenue growth<\/li> <li><strong>High volatility<\/strong>: 40.1% annualized volatility means wild price swings<\/li> <li><strong>Competition pressure<\/strong>: Pfizer and Novo Nordisk are circling their markets<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Revenue explosion<\/strong>: 339% growth isn't a typo\u2014it's reality<\/li> <li><strong>Market expansion<\/strong>: YORVIPATH now in 75+ countries globally<\/li> <li><strong>Cash reserves<\/strong>: \u20ac494 million war chest for operations<\/li> <li><strong>Analyst love<\/strong>: 16 out of 16 analysts rate it Buy or Strong Buy<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Wait for November<\/strong>: The FDA decision is too big to ignore\u2014position after the news<\/li> <li><strong>Start small<\/strong>: Use dollar-cost averaging with 2-3% portfolio allocation<\/li> <li><strong>Set stop-losses<\/strong>: At $175 (30-day support) and $150 (200-day MA)<\/li> <li><strong>Monitor earnings<\/strong>: Q3 report on November 13th will show commercial progress<\/li> <\/ol> <p>Humorous take: \"Trading ASND is like dating a brilliant scientist\u2014incredibly rewarding but prone to dramatic mood swings. Bring your emotional stability and a strong stomach!\"<\/p> <h2>\u2705 How to Buy Ascendis Pharma A\/S (ASND) Shares - Step by Step<\/h2> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ access and fractional shares<\/td><\/tr> <tr><td>2<\/td><td>Complete account funding<\/td><td>Start with an amount you're comfortable potentially losing<\/td><\/tr> <tr><td>3<\/td><td>Search \"ASND\"<\/td><td>Use the ticker symbol, not just the company name<\/td><\/tr> <tr><td>4<\/td><td>Select order type<\/td><td>Limit orders prevent overpaying during volatility<\/td><\/tr> <tr><td>5<\/td><td>Execute purchase<\/td><td>Review fees\u2014aim for less than 1% total commission<\/td><\/tr> <\/tbody> <\/table> <h3>Why Pocket Option Fits New Investors<\/h3> <p>Pocket Option makes biotech investing accessible for everyone:<\/p> <ul> <li><strong>$5 minimum deposit<\/strong>\u2014test strategies with real money without breaking the bank<\/li> <li><strong>1-minute verification<\/strong>\u2014upload any ID document and start trading immediately<\/li> <li><strong>100+ withdrawal methods<\/strong>\u2014crypto, e-wallets, bank cards for flexibility<\/li> <li><strong>Fractional shares<\/strong>\u2014buy pieces of expensive stocks like ASND<\/li> <\/ul> <h2>\ud83c\udf0d Ascendis Pharma in 2025: The TransCon Revolution<\/h2> <p>Ascendis Pharma isn't just another biotech company\u2014it's pioneering the future of endocrine rare disease treatment. Their TransCon technology platform represents a genuine breakthrough, allowing sustained drug release with fewer injections.<\/p> <p>The company currently dominates the growing market for growth hormone disorders and hypoparathyroidism treatments. With YORVIPATH achieving over 3,100 patient prescriptions by mid-2025 and SKYTROFA expanding into adult markets, the commercial engine is firing on all cylinders.<\/p> <p><strong>2025 Fun Fact<\/strong>: Ascendis Pharma's Copenhagen headquarters features a \"molecule sculpture garden\" where employees can walk among giant models of their TransCon compounds. Scientists literally stroll through their innovations during lunch breaks!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Ascendis Pharma Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 25, 2025, Ascendis Pharma A\/S (ASND) trades at <strong>$194.30<\/strong> on NASDAQ. Mark your calendar: <strong>November 13, 2025<\/strong> is absolutely critical\u2014that&#8217;s when the company releases its Q3 earnings report. But the real game-changer comes just before that&#8230;<\/p>\n<p><strong>November 30, 2025<\/strong> is the FDA&#8217;s PDUFA date for TransCon CNP approval. This single decision could make or break the stock&#8217;s trajectory for the next year. Historically, FDA decisions on Ascendis products have created massive price swings.<\/p>\n<h3>How FDA Decisions Move ASND Stock<\/h3>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 2024<\/td>\n<td>YORVIPATH Approval<\/td>\n<td>$145<\/td>\n<td>+28% (1 week)<\/td>\n<\/tr>\n<tr>\n<td>Mar 2025<\/td>\n<td>SKYTROFA Expansion<\/td>\n<td>$168<\/td>\n<td>+15% (3 days)<\/td>\n<\/tr>\n<tr>\n<td>Jan 2025<\/td>\n<td>Clinical Trial Results<\/td>\n<td>$132<\/td>\n<td>-12% (disappointing data)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern is clear: positive regulatory news drives double-digit gains, while setbacks cause significant corrections. The November decision represents the biggest catalyst of 2025.<\/p>\n<h3>6-Month Price Journey (February-August 2025)<\/h3>\n<p>ASND shares delivered an impressive <strong>75% surge<\/strong> during this period:<\/p>\n<ul>\n<li><strong>February<\/strong>: $111.09 (52-week low, market uncertainty)<\/li>\n<li><strong>April<\/strong>: $150.12 (breaking through 200-day moving average)<\/li>\n<li><strong>June<\/strong>: $188.79 (approaching all-time highs)<\/li>\n<li><strong>August<\/strong>: $194.30 (consolidating near peak levels)<\/li>\n<\/ul>\n<p>Why the dramatic climb? Three words: <strong>explosive revenue growth<\/strong>. The company&#8217;s Q2 2025 results showed a staggering <strong>339% revenue increase<\/strong> to \u20ac158 million, driven by successful launches of YORVIPATH and SKYTROFA.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<ul>\n<li><strong>2025 Year-End<\/strong>: $220-240 (pending FDA approval) \u2192 <strong>STRONG BUY<\/strong> if approved<\/li>\n<li><strong>2026<\/strong>: $260-300 (full commercialization of TransCon CNP)<\/li>\n<li><strong>2028<\/strong>: $380-450 (pipeline expansion and international growth)<\/li>\n<li><strong>2030<\/strong>: $550-650 (market leadership in endocrine rare diseases)<\/li>\n<\/ul>\n<p>The verdict? This is a <strong>high-risk, high-reward opportunity<\/strong> perfect for investors who can stomach biotech volatility. The November FDA decision is everything\u2014approval could launch this stock into orbit.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>FDA rejection risk<\/strong>: 20-30% potential drop if TransCon CNP isn&#8217;t approved<\/li>\n<li><strong>Financial losses<\/strong>: \u20ac38.9M net loss despite huge revenue growth<\/li>\n<li><strong>High volatility<\/strong>: 40.1% annualized volatility means wild price swings<\/li>\n<li><strong>Competition pressure<\/strong>: Pfizer and Novo Nordisk are circling their markets<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Revenue explosion<\/strong>: 339% growth isn&#8217;t a typo\u2014it&#8217;s reality<\/li>\n<li><strong>Market expansion<\/strong>: YORVIPATH now in 75+ countries globally<\/li>\n<li><strong>Cash reserves<\/strong>: \u20ac494 million war chest for operations<\/li>\n<li><strong>Analyst love<\/strong>: 16 out of 16 analysts rate it Buy or Strong Buy<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Wait for November<\/strong>: The FDA decision is too big to ignore\u2014position after the news<\/li>\n<li><strong>Start small<\/strong>: Use dollar-cost averaging with 2-3% portfolio allocation<\/li>\n<li><strong>Set stop-losses<\/strong>: At $175 (30-day support) and $150 (200-day MA)<\/li>\n<li><strong>Monitor earnings<\/strong>: Q3 report on November 13th will show commercial progress<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading ASND is like dating a brilliant scientist\u2014incredibly rewarding but prone to dramatic mood swings. Bring your emotional stability and a strong stomach!&#8221;<\/p>\n<h2>\u2705 How to Buy Ascendis Pharma A\/S (ASND) Shares &#8211; Step by Step<\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ access and fractional shares<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account funding<\/td>\n<td>Start with an amount you&#8217;re comfortable potentially losing<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search &#8220;ASND&#8221;<\/td>\n<td>Use the ticker symbol, not just the company name<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select order type<\/td>\n<td>Limit orders prevent overpaying during volatility<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Execute purchase<\/td>\n<td>Review fees\u2014aim for less than 1% total commission<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3>Why Pocket Option Fits New Investors<\/h3>\n<p>Pocket Option makes biotech investing accessible for everyone:<\/p>\n<ul>\n<li><strong>$5 minimum deposit<\/strong>\u2014test strategies with real money without breaking the bank<\/li>\n<li><strong>1-minute verification<\/strong>\u2014upload any ID document and start trading immediately<\/li>\n<li><strong>100+ withdrawal methods<\/strong>\u2014crypto, e-wallets, bank cards for flexibility<\/li>\n<li><strong>Fractional shares<\/strong>\u2014buy pieces of expensive stocks like ASND<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Ascendis Pharma in 2025: The TransCon Revolution<\/h2>\n<p>Ascendis Pharma isn&#8217;t just another biotech company\u2014it&#8217;s pioneering the future of endocrine rare disease treatment. Their TransCon technology platform represents a genuine breakthrough, allowing sustained drug release with fewer injections.<\/p>\n<p>The company currently dominates the growing market for growth hormone disorders and hypoparathyroidism treatments. With YORVIPATH achieving over 3,100 patient prescriptions by mid-2025 and SKYTROFA expanding into adult markets, the commercial engine is firing on all cylinders.<\/p>\n<p><strong>2025 Fun Fact<\/strong>: Ascendis Pharma&#8217;s Copenhagen headquarters features a &#8220;molecule sculpture garden&#8221; where employees can walk among giant models of their TransCon compounds. Scientists literally stroll through their innovations during lunch breaks!<\/p>\n"},"faq":[{"question":"Is Ascendis Pharma profitable yet?","answer":"Not yet\u2014the company reported a \u20ac38.9M net loss in Q2 2025 despite massive revenue growth. This is typical for biotech companies investing heavily in R&D and commercialization."},{"question":"What's the biggest risk for ASND stock?","answer":"The November 30, 2025 FDA decision on TransCon CNP. Rejection could drop the stock 20-30%, while approval could drive similar gains upward."},{"question":"How volatile is ASND compared to other stocks?","answer":"Extremely volatile\u201440.1% annualized volatility means much larger price swings than the overall market. Only suitable for risk-tolerant investors."},{"question":"What products does Ascendis currently sell?","answer":"YORVIPATH for hypoparathyroidism ($103M Q2 revenue) and SKYTROFA for growth hormone deficiency ($51M Q2 revenue), with TransCon CNP potentially launching soon."},{"question":"Should I buy before or after the FDA decision?","answer":"Most conservative investors wait until after binary events like FDA decisions. The potential reward isn't worth the risk of a 30% overnight drop for most beginners."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is Ascendis Pharma profitable yet?","answer":"Not yet\u2014the company reported a \u20ac38.9M net loss in Q2 2025 despite massive revenue growth. This is typical for biotech companies investing heavily in R&D and commercialization."},{"question":"What's the biggest risk for ASND stock?","answer":"The November 30, 2025 FDA decision on TransCon CNP. Rejection could drop the stock 20-30%, while approval could drive similar gains upward."},{"question":"How volatile is ASND compared to other stocks?","answer":"Extremely volatile\u201440.1% annualized volatility means much larger price swings than the overall market. Only suitable for risk-tolerant investors."},{"question":"What products does Ascendis currently sell?","answer":"YORVIPATH for hypoparathyroidism ($103M Q2 revenue) and SKYTROFA for growth hormone deficiency ($51M Q2 revenue), with TransCon CNP potentially launching soon."},{"question":"Should I buy before or after the FDA decision?","answer":"Most conservative investors wait until after binary events like FDA decisions. The potential reward isn't worth the risk of a 30% overnight drop for most beginners."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Ascendis Pharma A\/S (ASND) shares - Investment in Ascendis Pharma A\/S (ASND) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Ascendis Pharma A\/S (ASND) shares - Investment in Ascendis Pharma A\/S (ASND) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T19:47:18+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Ascendis Pharma A\/S (ASND) shares &#8211; Investment in Ascendis Pharma A\/S (ASND) stock\",\"datePublished\":\"2025-08-25T19:47:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\",\"name\":\"How to buy Ascendis Pharma A\/S (ASND) shares - Investment in Ascendis Pharma A\/S (ASND) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"datePublished\":\"2025-08-25T19:47:18+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Ascendis Pharma A\/S (ASND) shares &#8211; Investment in Ascendis Pharma A\/S (ASND) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Ascendis Pharma A\/S (ASND) shares - Investment in Ascendis Pharma A\/S (ASND) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Ascendis Pharma A\/S (ASND) shares - Investment in Ascendis Pharma A\/S (ASND) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T19:47:18+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Ascendis Pharma A\/S (ASND) shares &#8211; Investment in Ascendis Pharma A\/S (ASND) stock","datePublished":"2025-08-25T19:47:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/","name":"How to buy Ascendis Pharma A\/S (ASND) shares - Investment in Ascendis Pharma A\/S (ASND) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","datePublished":"2025-08-25T19:47:18+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals15-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Ascendis Pharma A\/S (ASND) shares &#8211; Investment in Ascendis Pharma A\/S (ASND) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":350607,"slug":"how-to-buy-ascendis-pharma-as","post_title":"Comment acheter des actions Ascendis Pharma A\/S (ASND) - Investissement dans les actions Ascendis Pharma A\/S (ASND)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"},"it_IT":{"locale":"it_IT","id":350608,"slug":"how-to-buy-ascendis-pharma-as","post_title":"Come acquistare azioni Ascendis Pharma A\/S (ASND) - Investimento in azioni Ascendis Pharma A\/S (ASND)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"},"pl_PL":{"locale":"pl_PL","id":350614,"slug":"how-to-buy-ascendis-pharma-as","post_title":"Jak kupi\u0107 akcje Ascendis Pharma A\/S (ASND) - Inwestycja w akcje Ascendis Pharma A\/S (ASND)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"},"es_ES":{"locale":"es_ES","id":350611,"slug":"how-to-buy-ascendis-pharma-as","post_title":"C\u00f3mo comprar acciones de Ascendis Pharma A\/S (ASND) - Inversi\u00f3n en acciones de Ascendis Pharma A\/S (ASND)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"},"th_TH":{"locale":"th_TH","id":350613,"slug":"how-to-buy-ascendis-pharma-as","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Ascendis Pharma A\/S (ASND) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Ascendis Pharma A\/S (ASND)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"},"tr_TR":{"locale":"tr_TR","id":350612,"slug":"how-to-buy-ascendis-pharma-as","post_title":"Ascendis Pharma A\/S (ASND) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ascendis Pharma A\/S (ASND) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"},"vt_VT":{"locale":"vt_VT","id":350609,"slug":"how-to-buy-ascendis-pharma-as","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Ascendis Pharma A\/S (ASND)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"},"pt_AA":{"locale":"pt_AA","id":350610,"slug":"how-to-buy-ascendis-pharma-as","post_title":"Como comprar a\u00e7\u00f5es da Ascendis Pharma A\/S (ASND) - Investimento em a\u00e7\u00f5es da Ascendis Pharma A\/S (ASND)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-ascendis-pharma-as\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/350590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=350590"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/350590\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334117"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=350590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=350590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=350590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}